A randomized double-blind controlled clinical trial demonstrating efficacy of different probiotic strains on serum lipids and glycemic biomarker.
- 2024-08-01
- RCT · n = 51
- Nutricion hospitalaria 41(4)
- Gözde Okburan
- Murat Baş
- Sultan Ogmen
- PubMed: 38967303
- DOI: 10.20960/nh.04724
- High evidence
- Clinical
Also, hs-CRP levels was assessed as inflammatory parameter.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 1 × 10^6 CFU/day